Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities
Net loss	$ (12,624,339)	$ (4,265,887)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	392,404	461,432
Deferred tax provision	1,662	0
Noncash interest expense	1,598,312	20,883
Share-based compensation	1,172,231	80,457
Inventory obsolescence	0	(44,595)
Change in fair value of derivative financial instruments and other	647,342	(4,400)
Changes in operating assets and liabilities, net of effects of acquisition:
Accounts receivable	507,066	62,251
Inventory	288,126	(159,174)
All other assets	(306,386)	78,311
Accounts payable	(814,855)	29,853
Accrued compensation and other liabilities	(1,752,790)	(42,778)
Deferred revenue	(180,311)	(121,551)
Net cash used in operating activities	(11,071,538)	(3,905,198)
Cash flows from investing activities
Cash acquired in business combination	1,367,211	0
Purchases of property and equipment	(89,234)	(39,537)
Net cash provided by (used in) investing activities	1,277,977	(39,537)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs	4,958,335	0
Proceeds from issuance of preferred stock, net of issuance costs	0	1,937,902
Proceeds from issuance of convertible notes and warrants, net of issuance costs	1,388,815	1,472,386
Proceeds from issuance of promissory notes, net of issuance costs	1,741,667	0
Proceeds from exercise of stock options and warrants	214	0
Proceeds from initial public offering, net of issuance costs paid in 2015	12,408,285	0
Payments on debt	(153,750)	(3,750)
Payments on capital lease obligations	(112,200)	(80,575)
Net cash provided by financing activities	20,231,366	3,325,963
Effects of exchange rates on cash	(193)	0
Net (decrease) increase in cash and cash equivalents	10,437,612	(618,772)
Cash and cash equivalents at beginning of period	749,517	1,400,345
Cash and cash equivalents at end of period	11,187,129	781,573
Supplemental disclosure of cash flow information
Cash paid during the period for interest	201,233	26,088
Supplemental disclosure of noncash investing and financing activities:
Acquisition of equipment purchased through capital leases	429,320	0
Common stock issued in business combination	2,584,090	0
Debt Conversion, Converted Instrument, Amount	300,000	0
IPO [Member]
Supplemental disclosure of noncash investing and financing activities:
Debt Conversion, Converted Instrument, Amount	2,100,000	0
Series A Preferred Stock [Member]
Supplemental disclosure of noncash investing and financing activities:
Debt Conversion, Converted Instrument, Amount	$ 3,000,000	$ 0